Ex Parte Datesman et al - Page 11



           Appeal No. 2006-1095                                                  Page 11             
           Application No. 10/280,188                                                                

           separately to the patentability of dependent claims 12-15 and 18-23. See                  

           In re Nielson, 816 F.2d 1567, 1572, 2 USPQ2d 1525, 1528 (Fed. Cir. 1987).                 

           See also 37 C.F.R. § 41.37(c)(1)(vii)(2004).  Therefore, we will also sustain             

           the examiner’s rejection of these claims as being anticipated by Boiarski for             

           the same reasons set forth in the rejection.                                              



           II.  We consider next the examiner’s rejection of claims 1, 2, 12-15, 18-                 

           20, 22 and 23 as being anticipated by Dietz.  Since Appellants’ arguments                 

           with respect to this rejection have treated these claims as a single group                

           which stand or fall together, we will consider independent claim 1 as the                 

           representative claim for this rejection. See 37 C.F.R. § 41.37(c)(1)(vii)                 

           (2004).                                                                                   

                 Appellants argue that Dietz does not teach multiple electromagnetic                 

           modes of propagation, at least with respect to interactions at the coupling               

           region, affecting the interaction of the propagational modes, as required by              

           the language of claim 1 [brief, page 5].                                                  

                 The examiner notes that Dietz discloses that the surface or layer that              

           is altered with a specific molecule, antigen and/or antibody has an index of              

           refraction that is proportional to the concentration of chemical or biological            

           agents attached to the molecules, antigen and/or antibodies on the surface                








Page:  Previous  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  Next 

Last modified: November 3, 2007